Home›People›Jussi Paananen
JP

Jussi Paananen

CTO & Co-founder, director at SwitchPoint Bio Holding.

ExecutiveDirector
Updated Nov 11, 2026·Latest SEC filing Mar 10, 2026·Suggest an edit

About Jussi Paananen

Jussi Paananen is CTO & Co-founder, director at SwitchPoint Bio Holding.

Experience

This experience comes from Jussi Paananen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jussi Paananen in the role, so the role may have started earlier or lasted longer.

SwitchPoint Bio Holding, Inc. Current
CTO & Co-founder, director
Chief Technology Officer, Co-Founder (2026 – Present)
2026 – Present · Wilmington, DE
Analyzes blood cell biology for drug developers and clinical researchers.
Broad Institute of MIT and Harvard
Visiting Scientist
2006 – 2026
Meru Health
Chief Technology Officer
2023 – 2024
Quest Diagnostics
Executive Director
2020 – 2023
Nursie Health Oy
Vice-Chairman Of The Board
2020 – 2021
Blueprint Genetics
Chief Technology Officer
2017 – 2020
Afekta Technologies
Chairman Of The Board
2017 – 2019
Genomi Solutions Ltd.
Chairman Of The Board
2008 – 2019
The Research Ethics Committee of the Northern Savo Hospital District
Member
2016 – 2018
University of Eastern Finland
Research Manager (2003 – 2018)
Assistant Professor (2015 – 2018)
Senior Researcher (2013)
Bioinformatics Specialist (part-time) (2010 – 2013)
Bioinformatician (2011 – 2013)
2003 – 2018
Kuopio University Hospital (KUH) / Neurosurgery
Researcher
2015
La-Ti Palvelut Oy
Vice Member of the Board
1998 – 2012
University of Kuopio, Institute of Clinical Medicine
Senior Researcher
2009 – 2010
University of Kuopio, Deparment of Biosciences
Senior Bioinformatician
2008
University of Kuopio, Department of Biosciences
Researcher/Doctoral student
2007 – 2008
Kuopion Mikronikkarit Oy
Computer Engineer
1998 – 1999

Key Colleagues at Startups

The people Jussi Paananen works with at each company, as listed on that company's latest Form D.

SwitchPoint Bio Holding, Inc. · Form D, Mar 10, 2026
DP
SM
Samuel Myllykangas
CEO & Co-founder, director

Sources

  1. SECSwitchPoint Bio Holding, Inc. Form D, filed Mar 10, 2026